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 Short Communication 
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 IGF-I receptor phosphorylation is impaired in 
cathepsin X-deficient prostate cancer cells 
 Abstract:  The cysteine-type peptidase cathepsin X is highly 
upregulated in several cancers and presumably promotes 
tumor invasion through bypassing cellular senescence. 
Here, we present first evidence that the underlying mecha-
nism may involve the regulation of the insulin-like growth 
factor (IGF) system, a well-known activator of proliferat-
ing tumor cells. Cathepsin X deficiency leads to a reduced 
phosphorylation of the IGF-I receptor in response to IGF-I 
stimulation. In addition, downstream signaling through 
focal adhesion kinase was also affected. Taken together, 
our results indicate that cathepsin X is able to assist in IGF 
signaling, which may be an important progress toward 
understanding cathepsin X-dependent tumorigenesis. 
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 The insulin-like growth factor (IGF) pathway fulfills impor-
tant functions in growth, development, and survival and 
has also been implicated in the pathogenesis of malignan-
cies (Hanahan and Weinberg , 2000 ; Pollak , 2008 ). On the 
one hand, IGFs may promote excessive and uncontrolled 
cell division through the activation of cell cycle progres-
sion and inhibition of apoptosis, thereby contributing to 
cancer development. On the other hand, the modulation 
of the IGF axis can alter aging phenotypes and longevity 
in animal models as well as the life span of cells in culture 
(Kamrava et al. , 2011 ). 
 Within the last decade, cellular senescence has 
emerged as a safety mechanism that irreversibly arrests 
the proliferation of damaged cells that are at risk for malig-
nant transformation (Campisi , 2001 ; Smith and Kipling , 
2004 ). Hence, cancer cells have adopted several ways 
to overcome this powerful tumor suppressor pathway. 
Besides mutations in senescence-relevant genes such as 
 p53 , one such mechanism seems to act through lysosomal 
cathepsins such as cathepsin X, which is upregulated in 
several cancers ( N ä gler et al., 2004 ; Krueger et al. , 2005 ) 
and has been shown to participate in invasive processes 
(Sevenich et al. , 2010 ). Remarkably, the downregulation 
of cathepsin X leads to accelerated cellular senescence 
(Kraus et al. , 2011 ). Apart from bypassing cellular senes-
cence, tumor invasion due to upregulated cathepsin X has 
also been suggested to be promoted through alternative 
mechanisms such as compensation for the loss of cathep-
sin B in primary cells (Vasiljeva et al. , 2006 ) or the induc-
tion of epithelial-mesenchymal transition (Wang et al. , 
2011 ). 
 Evidence is accumulating that cathepsins play sig-
nificant roles in signal transduction pathways (see, for 
example, Malla et al. , 2010 ; Chen et al. , 2012 ). Members 
of this group of enzymes carry mannose-6-phosphate 
(M6P) recognition moieties to be sorted to lysosomes  via 
the  cation-dependent M6P receptor (MPR). Cathepsins are 
also secreted by many cancers and can be reinternalized 
by interacting with the IGF-II/cation-independent MPR 
and thereby possibly modulating IGF signaling. Notably, 
the expression of IGFs inversely correlates with prolif-
erative aging. For example, IGF-II levels are decreased 
in senescent human fibroblasts (Kanzaki et al. , 2002 ), 
whereas IGF-I was shown to reduce the senescence of 
intervertebral annulus cells  in vitro (Gruber et al. , 2008 ), 
and its synthesis decreases in murine submandibular 
glands with aging (Kobayashi et al. , 2004 ). Therefore, we 
hypothesized that alterations within the IGF axis could 
lead to the observed senescent phenotypes in cathepsin 
X-deficient cells. To test this hypothesis, we used RNA 
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interference to achieve selective knockdown of cathepsin 
X in two human prostate carcinoma cell lines (PC-3 and 
LNCaP) and analyzed its contribution to IGF receptor acti-
vation. Here we present first evidence implicating cathep-
sin X in the IGF signaling pathways. 
 To determine if cathepsin X downregulation impairs 
the expression and activation of IGF receptors, we trans-
fected PC-3 and LNCaP prostate carcinoma cells with 
small interfering RNAs (siRNAs) targeting cathepsin X 
as well as with non-targeting control siRNAs and per-
formed quantitative RT-PCR and immunoblot analyses 
of the corresponding cell lysates. To exclude off-target 
effects of individual siRNAs, two siRNAs targeting dif-
ferent regions of the cathepsin X mRNA were initially 
applied, with similar results. For reasons of clarity, 
only data with one siRNA are shown. Furthermore, to 
exclude potential clonal differences, experiments were 
performed on pools of transiently transfected cells. As 
determined by quantitative RT-PCR as well as by immu-
noblotting, the downregulation of cathepsin X mRNA 
and protein was effective with levels between 80 % and 
90 % when determined 72 h after transfection (Figure  1 A 
and B). 
 Next, we evaluated the expression levels of growth 
factor receptors in cathepsin X-deficient prostate carci-
noma cells. Quantitative RT-PCR experiments indicated 
that cathepsin X deficiency is accompanied by an upregu-
lation of IGF-I receptor (IGF-IR) transcripts both in PC-3 
and LNCaP cells (Figure 1C and D). In contrast, the expres-
sion of the IGF-II receptor (IGF-IIR; cation-independent 
MPR) and of the cation-dependent MPR were not affected 
by cathepsin X knockdown in these cells. 
 Figure 1   Knockdown of cathepsin X by RNA interference and effects on mRNA levels of IGF receptors. 
 (A) mRNA transcripts and (B) cell lysates were analyzed by quantitative RT-PCR and immunoblotting 3 days after siRNA transfection as 
previously described (Kraus et al. , 2011 ). Cathepsin X downregulation after siRNA transfection was confirmed both at (A) the mRNA level 
and (B) the protein level, revealing knockdown efficiencies of 80 % – 90 % . The abundance of IGF-IR transcripts increases after cathepsin 
X knockdown in both (C) PC-3 cells and (D) LNCaP cells. In contrast, IGF-IIR/cation-independent MPR expression as well as mRNA levels 
of the cation-dependent MPR were not altered in cathepsin X-deficient cells. Bars represent means ± SD of three independent experi-
ments. Statistical significance was evaluated using Student  t- test for independent groups. A value of  p < 0.05 was considered statistically 
 significant. * p < 0.05, *** p < 0.001. Methods: PC-3 or LNCaP prostate carcinoma cells were transfected 3 days before the experiments with 
siRNAs targeting cathepsin X or with nonsilencing control siRNAs. SiRNAs were synthesized by Qiagen (Hilden, Germany). The sequence of 
the siRNA targeting cathepsin X was as follows: sense, CGG AUC GGA UCA ACA UCA AdTdT; antisense, UUG AUG UUG AUC CGA UCC GdTdT. 
All experiments were performed on pools of transiently transfected cells. 
Bereitgestellt von | Universitaetsbibliothek der LMU Muenchen
Angemeldet | 129.187.254.47
Heruntergeladen am | 31.10.13 15:07
S. Kraus et al.: Cathepsin X regulates IGF receptor phosphorylation      1459
 To investigate whether cathepsin X-deficient tumor 
cells display differences in IGF-IR activation, we stimulated 
PC-3 and LNCaP cells with IGF-I or IGF-II and evaluated 
the phosphorylation of the IGF-IR using a phosho-specific 
antibody. Similarly to the mRNA level, unstimulated cells 
expressed higher protein levels of the IGF-IR after cath-
epsin X knockdown (Figure  2 ). Overall, the expression of 
the IGF-IR was higher in PC-3 cells (Figure 2A) compared 
with LNCaP cells (Figure 2D), which is in good agreement 
with data from the literature (Krueckl et al. , 2004 ; Pandini 
et al. , 2005 ). In cells deficient of cathepsin X, stimula-
tion with IGF-I resulted in reduced phosphorylation com-
pared with control cells. If cells were stimulated with 
IGF-II, however, IGF-IR phosphorylation increased on an 
absolute level, but the phospho-IGF-IR/total IGF-IR ratio 
remained rather unaffected after cathepsin X knockdown 
(Figure 2C and F). 
 To further analyze the localization and altered IGF-IR 
activation in cathepsin X-deficient cells, we performed 
immunofluorescence on PC-3 cells. The IGF-IR appears 
to accumulate in smaller vesicles in cells lacking cath-
epsin X compared with control cells (Figure  3 A). After 
stimulation with IGF-I, the phosphorylated IGR-IR (p-IGF-
IR) was detected at the cell border only in control cells, 
but not after treatment with cathepsin X-specific siRNAs 
(Figure 3B). Focal adhesion kinase (FAK) is known to inter-
act with the activated IGF-IR and mediates IGF-I signals 
(Liu et al. , 2008 ; Andersson et al. , 2009 ; Ucar et al. , 2011 ). 
Co-immunostaining with p-FAK showed a similar stain-
ing pattern to the p-IGF-IR at the cell periphery in control 
cells but not in cathepsin X-deficient cells. In contrast, 
stimulation with IGF-II did not lead to major differences 
in staining patterns of both p-IGF-IR and p-FAK, which is 
in good agreement with the immunoblotting results (data 
not shown). These results suggest that cathepsin X may 
mediate IGF-I signaling in a FAK-dependent manner. 
 Surprisingly, the effects of IGF-I and IGF-II on the 
proliferation of prostate cancer cells were not significant 
(data not shown). The cells did not respond to any of the 
growth factors in a CyQUANT proliferation assay. Instead, 
the cells were able to grow in serum-free medium, and 
neither IGF-I nor IGF-II could induce a further increase 
in proliferation. A possible explanation for this finding is 
that certain cancer cell lines possess a dramatically dereg-
ulated cell cycle leading to uncontrolled proliferation, 
which is virtually independent from growth factor abun-
dance. A similar observation was reported for bladder 
cancer cells, which did not respond to IGF-I in terms of 
proliferation, whereas motility and invasion could be pos-
itively influenced by this growth hormone (Metalli et al. , 
2010 ). Meanwhile, matching our previous results with 
 Figure 2   Effects of cathepsin X knockdown on IGF receptor 
 phosphorylation. 
 (A) Similarly to mRNA levels, total IGF-IR is increased in PC-3 cells 
lacking cathepsin X, whereas phosphorylated IGF-IR appears to be 
decreased after stimulation with IGF-I. In contrast, the ratio of phospho-
IGF-IR to total IGF-IR does not change after stimulation with IGF-II. The 
levels of the IGF-IIR were unaffected by cathepsin X siRNA treatment. 
(B) and (C) Densitometric analysis of immunoblots shown in (A). (D) – (F) 
Immunoblots and densitometric analysis from similar experiments per-
formed with LNCaP cells. Densitometric analysis was performed using 
ImageJ (Girish and Vijayalakshmi , 2004 ). Methods: PC-3 or LNCaP pros-
tate carcinoma cells were transfected 3 days before the experiments 
with siRNAs targeting cathepsin X or with nonsilencing control siRNAs. 
Cells were starved for 4 h in serum-free medium and were then stimu-
lated with 50 ng/ml IGF-I or 200 ng/ml IGF-II, respectively. After 20 min 
(IGF-I) or 10 min (IGF-II) of stimulation, cells were lysed on ice in SDS 
sample buffer containing Protease Inhibitor Cocktail III (Calbiochem/
Merck, Darmstadt, Germany) and 1 m m Na 3 VO 4 (Merck, Darmstadt, 
Germany). Lysates were analyzed by immunoblotting using antibodies 
for IGF-IR (1:1000; Cell Signaling, Danvers, MA, USA), p-IGF-IR (1:1000; 
Cell Signaling), IGF-IIR (1:1000; R&D Systems, Minneapolis, MN, USA), 
and actin (1:500; Sigma-Aldrich, St. Louis, MO, USA). 
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other cell types, there was a slight decrease in prolifera-
tion due to cathepsin X deficiency. With regard to the role 
of cathepsin X in invasive processes, transwell (Boyden 
chamber) assays had previously revealed a decreased 
invasive potential of tumor cells lacking cathepsin X 
(Krueger et al. , 2005 ). Similarly, cathepsin X-deficient PC-3 
cells display a reduction of the invasive capacity in trans-
migration assays (data not shown). 
 Taken together, our results indicate that cathepsin X 
is able to modulate IGF signaling and partly explain our 
previous findings regarding the accelerated cellular senes-
cence of cathepsin X-deficient cells (Kraus et al. , 2011 ). 
Increased IGF-IR expression and abundance could be a 
result of compensatory effects taking into account that 
receptor activation upon IGF-I stimulation is decreased in 
cathepsin X-deficient prostate cancer cells. Remarkably, 
cathepsin X deficiency leads to decreased IGF-IR phos-
phorylation in response to IGF-I but not IGF-II stimulation. 
Similarly, downstream signaling events such as phospho-
rylation of FAK were affected in cathepsin X-deficient PC-3 
cells only after stimulation with IGF-I. 
 In this context, our results suggest that other factors 
may be involved in IGF-II-induced signaling. IGF-II can 
bind with high affinity to both the IGF-I and the IGF-II/
cation-independent MPR. The IGF-IIR is not involved 
in growth-promoting signal transduction pathways; 
however, it is thought to act as a sink for IGF-II, thereby 
preventing this growth factor to activate the IGF-IR (Ellis 
et al. , 1996 ). Meanwhile, extracellular cathepsins are 
also able to interact with the IGF-II receptor  via their M6P 
moiety. As a consequence, the enzyme-receptor complexes 
are internalized, leading to a decrease of the number of 
receptor molecules at the cell surface. As cathepsin X is 
the main lysosomal enzyme secreted from prostate cancer 
cells (data not shown), its reinternalization through its 
interaction with the IGF-II/cation-independent MPR may 
drive extracellular IGF-II molecules to activate the IGF-IR, 
thereby inducing IGF signaling. In turn, cathepsin X 
downregulation may lead to an increased internalization 
of IGF-II and thereby contribute to impaired IGF signal-
ing. Taking into account that both PC-3 and LNCaP cells 
produce endogenous IGF-II, this model is supported by 
our finding that cathepsin X deficiency leads to reduced 
activation of the IGF-IR in response to IGF-I. 
 Hence, these results reflect the complexity of the 
underlying mechanism. As cathepsin X deficiency does 
not induce changes in IGF-II-dependent IGF-IR phospho-
rylation, cathepsin X appears to act mainly on the IGF-I 
axis. 
 Cathepsin X could also be involved in the processing 
of IGF-binding proteins, thereby disturbing the interaction 
 Figure 3   Subcellular localization of the IGF-IR in PC-3 cells. 
 (A) IGF-IR-positive vesicles are smaller and more evenly distributed 
in unstimulated cathepsin X-deficient PC-3 cells compared with cells 
expressing cathepsin X. (B) Upon stimulation with IGF-I, both phos-
phorylated IGF-IR and phosphorylated FAK appear to be partially 
co-localized at the cell border in control cells but not in cells treated 
with cathepsin X siRNAs (arrows). Methods: Three days after trans-
fection with siRNAs, cells were starved for 4 h in serum-free RPMI. 
Subsequently, IGF-I (50 ng/ml) was added to the cells. After 20 min 
of stimulation, cells were washed with PBS and fixed in 8 % formal-
dehyde/200 m m HEPES for 30 min at room temperature, washed 
again with 200 m m HEPES, permeabilized with 0.2 % Triton X-100 
in PBS followed by washing with PBS. Blocking was performed in 
3 % BSA/PBS for 30 min at 37 ° C. Next, samples were incubated 
with primary antibodies (diluted in 0.1 % BSA/PBS) targeting IGF-IR 
(1:200; Cell Signaling), p-IGF-IR (1:200; Abcam, Cambridge, UK), 
or p-FAK (1:200; BD Biosciences, Heidelberg, Germany) overnight 
at 4 ° C. Incubation with the respective secondary antibody (Alexa 
Fluor 488 goat anti-rabbit, 1:200; Alexa Fluor 568 goat anti-mouse, 
1:200; Molecular Probes/Life Technologies, Darmstadt, Germany) 
was performed for 1 h at room temperature in 0.1 % BSA/PBS. After 
a final wash, cover slips were mounted with ProLong Gold Antifade 
Reagent with DAPI (Molecular Probes/Life Technologies). Images 
were collected on a Carl Zeiss Axioskop upright microscope using a 
Canon EOS 60D digital camera. Scale bars represent 25  μ m. 
Bereitgestellt von | Universitaetsbibliothek der LMU Muenchen
Angemeldet | 129.187.254.47
Heruntergeladen am | 31.10.13 15:07
S. Kraus et al.: Cathepsin X regulates IGF receptor phosphorylation      1461
between these and IGF-I and leading to a higher bioavail-
ability of IGF-I. Furthermore, recent evidence on the cross-
talk between the IGF-IR and the integrins adds a new level 
of complexity to cellular signaling (Beattie et al. , 2010 ). 
One could, therefore, also speculate on the interference 
of cathepsin X with the crosstalk between the IGF axis 
and the integrins because cathepsin X has been shown 
to physically interact with integrins (Lechner et al. , 2006 ; 
Jevnikar et al. , 2011 ). 
 Remarkably, a loss of responsiveness to IGF-I was 
also observed in cells with reduced cathepsin L expres-
sion levels; however, cathepsin L downregulation led 
to increased apoptosis rather than senescence (Navab 
et  al. , 2008 ). Therefore, the influence of cathepsins on 
IGF signaling is likely to be widespread and complicated, 
and further research will continue to advance our knowl-
edge regarding these mechanisms. In particular, the 
interference of cathepsin X with IGF signaling in normal, 
untransformed cells will reveal whether this mechanism 
is confined to tumor cells or cathepsin X and/or other 
cathepsins interfere with IGF signaling during normal 
regulation of growth-promoting pathways. 
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